Financial Results
Zensar Technologies Publishes Q2 FY27 Results
Zensar Technologies published newspaper advertisements for its unaudited Q2 FY27 financial results, approved by the Board on October 28, 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
7
Neutral
3
Bullish
4
Bearish
7
Neutral
3
Bullish
36
Bearish
0
Neutral
0
Bullish
32
View Standalone
View Standalone
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone

Zensar Technologies Ltd (ZENSARTECH) is currently trading at 535.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Zensar Technologies is a global digital solutions and IT services company that conceptualizes, builds, and manages digital products through experience design, data engineering, advanced analytics, cloud, engineering, and security services for more than 180 global clients. Q2FY27 marked a sharp sequential recovery, with constant-currency revenue growth of 4.1%, EBITDA margin expanding 120 basis points to 15.8%, and utilization reaching 87.6%. Growth was broad geographically, while BFSI delivered particularly strong momentum and became 50.3% of quarterly revenue. Artificial intelligence is becoming commercially material rather than experimental: AI-influenced deals constituted 36% of the order book, and Zensar reported production-oriented deployments spanning enterprise modernization, procurement, insurance workflows, customer support, inventory optimization, and travel platforms. The portfolio remains uneven by industry. BFSI grew 7.1% sequentially and 17.1% year-on-year in constant currency, but TMT declined 2.2% sequentially and 21.6% year-on-year, creating concentration risk as BFSI reached over half of quarterly revenue. Zensar combines a debt-free balance sheet with approximately $297.3 million of cash and investments, rising headcount, lower attrition, and increasing large-client counts. However, gross margin softened to 29.5%, PAT margin declined to 12.0%, and top-20 clients still represented 56.2% of revenue.
Over the past 52 weeks, Zensar Technologies Ltd has traded between a low of ₹416.55 and a high of ₹813.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Zensar Technologies Ltd has a market capitalization of approximately 12,242.34. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Zensar Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.61 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 12,242.34 Cr, Zensar Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Zensar Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Zensar Technologies Ltd is 15.61. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Zensar is merging M3BI LLC and Bridgeview Life Sciences LLC into Zensar Technologies Inc., its material wholly owned US subsidiary.
Zensar Technologies' board is scheduled to consider and approve the unaudited Q2 FY27 results on October 28, 2026.
The board meeting is scheduled for 2026-07-29 to consider and approve the Q1 FY27 unaudited financial results.
Zen Technologies reported consolidated revenue of Rs 141.6 crore for Q1 FY27, compared with Rs 178.1 crore in Q4 FY26 and Rs 158.2 crore in Q1 FY26.
Financial Results
Zensar Technologies published newspaper advertisements for its unaudited Q2 FY27 financial results, approved by the Board on October 28, 2026.
Earnings Call/Transcript
Zensar Technologies has made available the audio recording of its Q2FY27 results earnings call held on October 29, 2026.
Financial Results
Zensar Technologies announced consolidated Q2FY27 results, reporting $166.2 million revenue, 4.1% sequential constant-currency growth and EBITDA margin of 15.8%.
Scheme of Arrangement
Zensar Technologies’ Board approved the amalgamation of wholly owned subsidiary M3BI India with the company, subject to NCLT and other regulatory approvals.
Financial Results
Zensar Technologies approved unaudited standalone and consolidated financial results for the quarter ended September 30, 2026, along with the limited review report.

IT - Software
Computers - Software & Consulting
12,195 Cr
Moderate Risk
15.5
18.5
1.9
2.5
813.40
416.55
Sales CAGR
Profit CAGR
ROE
ROCE